PanAgora Asset Management »

4d Molecular Therapeutics In shares owned by PanAgora Asset Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by PanAgora Asset Management from 13F filings

Historical chart of PanAgora Asset Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by PanAgora Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by PanAgora Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.3M 102k 31.86
2023-12-31 $2.1M 104k 20.26
2023-09-30 $964k 76k 12.73

More positions owned by PanAgora Asset Management

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
salesforce (CRM)
Mastercard Incorporated Cl A (MA)
Coca-Cola Company (KO)
Wells Fargo & Company (WFC)
Alphabet Cap Stk Cl C (GOOG)
Visa Com Cl A (V)
Booking Holdings (BKNG)
Applied Materials (AMAT)

View all positions for PanAgora Asset Management

Top funds holding 4d Molecular Therapeutics In

Viking Global Investors
RA Capital Management
BVF
VR Adviser
Henderson Group
Vanguard Group
Arrowpoint Asset Management
Casdin Capital
Goldman Sachs Group
Dimensional Fund Advisors
Deutsche Bank Aktiengesellschaft
Eagle Health Investments
Assenagon Asset Management
Jpmorgan Chase & Co
Point72 Asset Management

View all funds holding 4d Molecular Therapeutics In